Rocket


Overview
Financials
News + Filings

 
 

Arcutis Biotherapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17
Revenues17.93.4
            Revenue growth425.9% 
Cost of goods sold19.74.1
Gross profit-1.8-0.7
            Gross margin-10.0%-20.4%
General and administrative1.80.7
EBIT-19.7-4.1
            EBIT margin-110.0%-120.4%
Pre-tax income-19.3-5.0
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-19.3-5.0
            Net margin-107.3%-145.9%
 
Diluted EPS($7.76)($3.58)
Shares outstanding (diluted)2.51.4
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy